TIFFANY JOHNSON: Open Payments
NPI 1285145342 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$445 in 22 payments from 7 companies in 2025. Trend: 2023 $336 · 2024 $511 · 2025 $445
Food & beverage: $445
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $170 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $121 |
| Otsuka America Pharmaceutical, Inc. | 2 | $50 |
| Lundbeck LLC | 2 | $43 |
| Janssen Pharmaceuticals, Inc | 1 | $24 |
| Tris Pharma Inc | 1 | $20 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
Products named: VRAYLAR, CAPLYTA, REXULTI, ABILIFY ASIMTUFII, Dyanavel XR, INGREZZA.
Industry payments across OH — which companies pay providers there.
